Form 4: Quest Diagnostics Director Lassiter Wright III Reports Acquisition of Restricted Share Units

Director Wright L. Lassiter III reports the acquisition of restricted share units and shares via dividend reinvestment in Quest Diagnostics.

Summary

• On May 16, 2024, Wright L. Lassiter III, a director of Quest Diagnostics Inc., reported acquiring 1,482 shares of common stock through an award of restricted share units.
• Additionally, Lassiter's holdings include shares acquired via dividend reinvestment since the last Form 4 filing, pursuant to the Amended and Restated Deferred Compensation Plan for Directors, resulting in a total of 7,709 shares beneficially owned following the reported transactions.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of share acquisition by a director, which is neither overtly positive nor negative.

Positives

• The acquisition of restricted share units by a director can be seen as a positive sign, aligning the director's interests with those of the shareholders.
• Dividend reinvestment indicates a long-term investment strategy and confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence due to the director's increased stake in the company.

Key Dates